acne ectopica acne inversa
Conditions
Interventions
Twenty patients will be randomly allocated to a one-sided single MWA treatment
in one axillary region with a miraDry device.
Hidradenitis suppurativa
Microwave ablation
Sweat gland
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: Key inclusion criteria: - Adult (* 18 years old) patients suffering from HS; - Minimum of 3 AN-count located in each axilla; - Maximum of 5 AN-count located in each axilla.
Exclusion criteria
Exclusion criteria: Key exclusion criteria: - >1 abscess or draining fistula per axillary area; - AN-count * 5 in other regions than the axillary area; - Surgical scars covering more than 25% of each individual axillary area; - Previous successful use of laser or light therapy for hair removal in the axillary area; - Use of botulinum toxin injections 6 months prior to randomization. - Pregnancy (at time of treatment)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical efficacy: Hidradenitis Suppurativa Clinical Response (HiSCR 50%), based on the lesion count (AN count). | — |
Secondary
| Measure | Time frame |
|---|---|
| - PROMs: number of flares, numerical rating scale on pain and itch, patient satisfaction; - Average number of hair containing follicles (dermatoscopy); - The extent of sweat production (starch-iodine test); - Safety parameters (adverse events). | — |
Countries
The Netherlands
Outcome results
None listed